Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa [NA]

View source ↗

Summary

This is a completed clinical trial studying Docosahexaenoic acid (DHA) supplementation in patients with X-linked retinitis pigmentosa. The sponsor was Retina Fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa
• X-linked Retinitis Pigmentosa

Drugs mentioned

• Docosahexaenoic acid (DHA) supplementation (docosahexaenoic acid)

Snippet

Sponsor: Retina Foundation of the Southwest | Conditions: Retinitis Pigmentosa | NA | Status: COMPLETED